potassium N,N-diphenyl-dithiocarbamate

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: potassium N,N-diphenyl-dithiocarbamate
• 英文别名: potassium;N,N-diphenylcarbamodithioate
• 化学式: C₁₃H₁₀NS₂*K
• 分子量: 283.459
• InChiKey: FSSKPSVRKSLRDX-UHFFFAOYSA-M

计算性质

• 辛醇/水分配系数(LogP)：
  0.66
• 重原子数：
  17
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  36.3
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  potassium chloroacetate 、 potassium N,N-diphenyl-dithiocarbamate 以 甲醇 为溶剂， 生成
  参考文献：
  名称：

  Nickel(II) thiohydrazide and thiodiamine complexes: Synthesis, characterization, antibacterial, antifungal and thermal studies

  摘要：

  Nickel(II) complexes of type [Ni(L)(2)Cl-2] and [Ni(L)(2)(OCOCH3)(2)], where L = N,N-diphenyl-N-thiohydrazide (L-1) and (N,N-diphenyl-N-thio)-1,3-propanediamine (L-2), have been synthesized. The thiodiamines coordinate as a bidentate N-S ligand. The synthesized nickel(II) complexes of the thiodiamines were characterized by elemental analysis, IR, mass, electronic and H-1 NMR spectroscopic and TG/DTA studies. Various kinetic and thermodynamic parameters like order of reaction (n), activation energy (E-a), apparent activation entropy (S-#) and heat of reaction (Delta H) have also been carried out for one complex. These complexes were also screened for in vitro antifungal and in vitro antibacterial activities and significant activity have been found. (c) 2007 Elsevier B.V. All rights reserved.

  DOI：

  10.1016/j.saa.2007.05.046
• 作为产物：
  描述：

  二硫化碳 、 二苯胺 在 potassium hydroxide 作用下， 以 乙醇 为溶剂， 反应 2.0h， 以88.6%的产率得到potassium N,N-diphenyl-dithiocarbamate
  参考文献：
  名称：

  混合偶氮连接席夫碱配体与二硫代氨基甲酸酯衍生物的金属配合物：形成，光谱表征和生物学研究。

  摘要：

  该研究包括混合偶氮连接的席夫碱和DTC配体及其配合物的制备和表征。从萘胺重氮盐与2-氨基苯酚在水中以1：1摩尔比的混合中分离出起始原料。在这项工作中，报道了偶氮连接的席夫碱和DTC配体的形成。通过起始原料与4-（二甲基氨基）苯甲醛）（HL1）的反应获得偶氮连接的席夫碱的配体。通过（C6H5）2NH与二硫化碳在氢氧化钾（L 2）中的反应分离出DTC。通过将偶氮连接的席夫碱配体和DTCs配体与金属盐混合来制备配合物。CoII，NiII，ZnII和CdII的摩尔比为1：1：1。配体和配合物的特征在于分析和光谱分析，包括：微量分析，氯化物含量，热分析，复合物的磁化率，电导，FTIR，UV-Vis和1H-NMR光谱。物理化学技术表明，复合物在固态和固溶态下显示出四个和六个坐标结构。筛选了配体及其金属配合物的生物活性，以研究它们对四种细菌（大肠埃希氏菌和革兰氏肠杆菌，顽固芽孢杆菌和金黄色葡萄球菌Garam

  DOI：

  10.13005/ojc/340340

文献信息

• Crystalline polyolefin composition
  申请人：Chisso Corporation

  公开号：EP0416321A1

  公开（公告）日：1991-03-13

  A crystalline polyolefin composition which provides molded articles having improved stiffness characteristics is disclosed, comprising 100 parts by weight of a crystalline polyolefin, (A) from 0.001 to 1 part by weight of a fluorophosphite compound represented by formula (I): wherein R represents an alkylidene group having from 1 to 4 carbon atoms or a sulfur atom; Ar1 and Ar2, which may be the same or different, each represents an alkylarylene group or a cycloalkylarylene group; and n represents 0 or 1, and (B) from 0.001 to 1 part by weight of at least one compound selected from the group consisting of (1) an aliphatic monocarboxylic acid salt with lithium or sodium, (2) a dithiocarbamic acid salt with lithium, sodium or potassium, (3) a 2-mercaptobenzothiazole salt with lithium, sodium or potassium, (4) a 2-mercaptobenzimidazole salt with lithium, sodium or potassium and (5) a benzotriazole salt with lithium, sodium or potassium. A crystalline polyolefin composition which provides molded articles having improved stiffness charateristics is also disclosed, comprising 100 parts by weight of a crystalline polyolefin, (A) from 0.001 to 1 part by weight of a fluorophosphite compound represented by formula (I) shown above, (B ) from 0.001 to 1 part by weight of at least one compound selected from the group consisting of (1) an aliphatic monocarboxylic acid salt with potassium, strontium or barium, (2) a hydroxy-higher fatty acid salt with potassium, strontium or barium, (3) an aliphatic polycarboxylic acid salt with lithium, sodium, potassium, strontium or barium, (4) a salt of an aliphatic hydroxy acid having form 2 to 6 carbon atoms with lithium, sodium, potassium, magnesium, strontium or barium, (5) an aromatic carboxylic acid salt with lithium, sodium, strontium, barium or aluminum, (6) a glutamic acid salt with lithium, sodium, potassium, strontium or barium, (7) an aliphatic phosphoric acid salt with sodium, potassium, calcium, strontium or barium, (8) a lithium, sodium, potassium or barium salt of a cyclic phosphorus compound represented by formula (II): wherein Ar3 and Ar4, which may be the same or different, each represents an arylene group, an alkylarylene group, a cycloalkylarylene group, an arylarylene group or an aralkylarylene group; M represents lithium, sodium, potassium or barium; and m represents an atomic valence of M, (9) magnesium or aluminum hydroxide, (10) magnesium oxide, (11) magnesium or calcium carbonate and (12) hydrotalcite, and (C) from 0.01 to 1 part by weight of an aliphatic amine.

  本发明公开了一种结晶聚烯烃组合物，该组合物可提供具有改进的刚度特性的模塑制品，该组合物包括按重量计100份的结晶聚烯烃、(A)按重量计0.001至1份的由式(I)代表的亚磷酸氟化合物： 其中 R 代表具有 1 至 4 个碳原子的亚烷基或硫原子；Ar1 和 Ar2 可以相同或不同，各自代表烷基芳基或环烷基芳基；n 代表 0 或 1，以及 (B) 0.(1) 锂或钠的脂肪族一羧酸盐，(2) 锂、钠或钾的二硫代氨基甲酸盐、(3) 锂、钠或钾的 2-巯基苯并噻唑盐， (4) 锂、钠或钾的 2-巯基苯并咪唑盐， (5) 锂、钠或钾的苯并三唑盐。 本发明还公开了一种结晶聚烯烃组合物，该组合物可提供具有改进的刚度特性的模塑制品，其成分包括 100 份（重量）结晶聚烯烃、(A) 0.001 至 1 份（重量）由上文式(I)代表的亚磷酸氟化合物、(B ) 0.(1)钾、锶或钡的脂肪族一羧酸盐；(2)钾、锶或钡的羟基高级脂肪酸盐；(3)锂、钠、钾、锶或钡的脂肪族多羧酸盐；(4)锂、钠、钾、镁、锶或钡的具有 2 至 6 个碳原子的脂肪族羟基酸盐、(5) 锂、钠、锶、钡或铝的芳香族羧酸盐； (6) 锂、钠、钾、锶或钡的谷氨酸盐、(7) 含有钠、钾、钙、锶或钡的脂肪族磷酸盐， (8) 由式（II）代表的环磷化合物的锂、钠、钾或钡盐： 其中 Ar3 和 Ar4 可以相同或不同，各自代表芳基、烷芳基、环烷芳基、芳基芳基或芳基芳基；M 代表锂、钠、钾或钡；m 代表 M 的原子价，(9) 氢氧化镁或铝，(10) 氧化镁，(11) 碳酸镁或碳酸钙和 (12) 水滑石，以及 (C) 0.01至1份重量的脂肪族胺。
• PROCESS FOR PREPARING 4-HYDROXYBUTYL ACRYLATE
  申请人：Osaka Organic Chemical Ind., Ltd.

  公开号：EP2860170B1

  公开（公告）日：2019-08-28
• Facile Synthesis of Novel Ionic Liquids Containing Dithiocarbamate
  作者：Dingjun Zhang、Jianmin Chen、Yongming Liang、Huidi Zhou

  DOI：10.1081/scc-200049773

  日期：2005.3

  The synthesis and characterization of several new ionic liquid derivatives containing dithiocarbamate, i.e., 3-methyl-1-[3-N,N-diethyldithiocarbamate-propyl]-imidazolium hexafluorophosphate 5a, 3-methyl-1-[3-N,N-dibutyldithiocarbamatepropyl]-imidazolium hexafluorophosphate 5b, 3-methyl-1-[3-N,N-dioctyldithiocarbamate-propyl]-imidazolium hexafluorophosphate 5c, 3-methyl-1-[3-N,N-diphenyl-dithiocarbamate-propyl]-imidazolium hexafluorophosphate 5d, 3-methyl-1-[3-morpholinedithiocarbamate-propyl]-imidazolium hexafluorophosphate 5e, 3-methyl-1-[3-pyridinedithiocarbamate-propyl]-imidazolium hexafluorophosphate 5f, and 3-methyl-1-[3-imidazoledithiocarbamate-propyl]-imidazolium hexafluorophosphate 5g, are described.
• Erol; Calis; Yulug, Bollettino Chimico Farmaceutico, 1995, vol. 134, # 11, p. 620 - 623
  作者：Erol、Calis、Yulug

  DOI：——

  日期：——
• US4870156A
  申请人：——

  公开号：US4870156A

  公开（公告）日：1989-09-26